Cover: Morning
(JANUARY 17, 2023).- This Tuesday, the undersecretary for Prevention and Health Promotion, Hugo López-Gatell Ramírez, reported that the COVID-19 pandemic has been on the rise for 12 consecutive weeks; however, vaccination has made the disease less severe.
The Mexican vaccine Patria, developed by the @Conacyt_MXdemonstrates the recovery of sovereignty and the country’s ability to develop health protection products.
Be part of the final stage of the clinical trial: https://t.co/PEVOURTuSE
— Hugo López-Gatell Ramírez (@HLGatell) January 17, 2023
In the morning press conference led by President Andrés Manuel López Obrador and before the Secretary of Health, Jorge Alcocer Varela, Undersecretary López-Gatell stressed that due to the protection provided by vaccines, the increase in hospitalizations and deaths is slight .
The hospital occupancy of general beds is eight percent and three percent in intensive therapy; deaths “are practically minimal” compared to previous waves, he detailed.
He reported that the Patria vaccine is in phase III, which corresponds to the clinical trial. It has been slower because there are few cases of the disease in this wave. Added to this situation is the success of having vaccinated 87 percent of the Mexican population.
In this context, he explained, it was decided that Patria, whose presentation is injectable and nasal, is a booster vaccine, and it is expected that the study sample will be completed in the following weeks. to move on to the analytical phase of the results and with this the Federal Commission for the Protection against Sanitary Risks (Cofepris) will define whether its registration for emergency use is authorized.
Undersecretary López-Gatell Ramírez explained that Patria is a project promoted by the National Council of Science and Technology (Conacyt), as a sign of the ability to develop health protection products, recovering sovereignty, and it is one of the most stable biologicals developed in the world with all the manufacturing phases.
LEARN MORE:
